Literature DB >> 15208661

Role of IFI 16 in cellular senescence of human fibroblasts.

Hong Xin1, Olivia M Pereira-Smith, Divaker Choubey.   

Abstract

Defects in interferon (IFN) signaling that result in loss of expression of IFN-inducible proteins are associated with cellular immortalization, an important early event in the development of human cancer. Here we report that loss of IFN-inducible IFI 16 expression in human fibroblasts allows bypass of cellular senescence. We found that levels of IFI 16 mRNA and protein were higher in human old versus young fibroblasts and immortalization of fibroblasts with telomerase resulted in decreased expression of IFI 16. Moreover, overexpression of IFI 16 in immortalized fibroblasts strongly inhibited cell proliferation. Interestingly, knockdown of IFI 16 expression in fibroblasts inhibited p53-mediated transcription, downregulated p21(WAF1) expression, and extended the proliferation potential. Importantly, treatment of immortal cell lines with 5-aza-2'-deoxycytidine, an inhibitor of DNA methyltransferase, resulted in upregulation of IFI 16. Our observations support the idea that increased levels of IFI 16 in older populations of human fibroblasts contribute to cellular senescence.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15208661     DOI: 10.1038/sj.onc.1207836

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  25 in total

1.  DNA damage signaling and p53-dependent senescence after prolonged beta-interferon stimulation.

Authors:  Olga Moiseeva; Frédérick A Mallette; Utpal K Mukhopadhyay; Adrian Moores; Gerardo Ferbeyre
Journal:  Mol Biol Cell       Date:  2006-01-25       Impact factor: 4.138

2.  Involvement of genes related to inflammation and cell cycle in idiopathic short stature.

Authors:  Letizia Trovato; Flavia Prodam; Giulia Genoni; Francesca De Rienzo; Gillian E Walker; Stefania Moia; Stefania Riccomagno; Simonetta Bellone; Gianni Bona
Journal:  Pituitary       Date:  2013-03       Impact factor: 4.107

Review 3.  Nuclear sensing of viral DNA, epigenetic regulation of herpes simplex virus infection, and innate immunity.

Authors:  David M Knipe
Journal:  Virology       Date:  2015-03-03       Impact factor: 3.616

4.  Genomic regulation of senescence and innate immunity signaling in the retinal pigment epithelium.

Authors:  Edward Chaum; Christina S Winborn; Sujoy Bhattacharya
Journal:  Mamm Genome       Date:  2015-05-12       Impact factor: 2.957

5.  Nutlin-3-induced redistribution of chromatin-bound IFI16 in human hepatocellular carcinoma cells in vitro is associated with p53 activation.

Authors:  Xin-li Shi; Jing Yang; Nan Mao; Jing-hua Wu; Lai-feng Ren; Yuan Yang; Xiao-lin Yin; Lin Wei; Ming-yuan Li; Bao-ning Wang
Journal:  Acta Pharmacol Sin       Date:  2014-12-29       Impact factor: 6.150

Review 6.  Differential network analysis in human cancer research.

Authors:  Ryan Gill; Somnath Datta; Susmita Datta
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

7.  Phosphoproteome dynamics in onset and maintenance of oncogene-induced senescence.

Authors:  Erik L de Graaf; Joanna Kaplon; Houjiang Zhou; Albert J R Heck; Daniel S Peeper; A F Maarten Altelaar
Journal:  Mol Cell Proteomics       Date:  2014-06-24       Impact factor: 5.911

8.  A pathologic link between Wilms tumor suppressor gene, WT1, and IFI16.

Authors:  Marianne K-H Kim; Jacqueline M Mason; Chi-Ming Li; Windy Berkofsky-Fessler; Le Jiang; Divaker Choubey; Paul E Grundy; Benjamin Tycko; Jonathan D Licht
Journal:  Neoplasia       Date:  2008-01       Impact factor: 5.715

Review 9.  Senescence-messaging secretome: SMS-ing cellular stress.

Authors:  Thomas Kuilman; Daniel S Peeper
Journal:  Nat Rev Cancer       Date:  2009-01-09       Impact factor: 60.716

10.  Interferon-inducible IFI16, a negative regulator of cell growth, down-regulates expression of human telomerase reverse transcriptase (hTERT) gene.

Authors:  Lynda Li Song; Larissa Ponomareva; Hui Shen; Xin Duan; Fatouma Alimirah; Divaker Choubey
Journal:  PLoS One       Date:  2010-01-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.